Prognostic significance of complement factors in severely ill patients with COVID-19

Area of Science:

• Immunology
• Virology
• Critical Care Medicine

Background:

• Severe COVID-19 involves coagulopathy, cytokine release, platelet hyperactivity, and endothelial activation.
• Complement activation may link these pathological factors in severe COVID-19.
• Understanding complement's role is crucial for predicting COVID-19 patient outcomes.

Purpose of the Study:

• To investigate the prognostic significance of specific complement factors in hospitalized patients with severe COVID-19.
• To determine if complement factor levels correlate with mortality, ICU admission, and hospital stay duration.
• To identify key complement factors as predictors of mortality in severe COVID-19.

Main Methods:

• Study included 300 hospitalized adults diagnosed with severe COVID-19.
• Serum levels of complement factors (C3, C3a, C4, sC5b-9) were measured using ELISA kits.
• Outcome measures included mortality, ICU admission, and length of hospital stay; statistical analyses, including multivariate logistic regression, were performed.

Main Results:

• Survivors had significantly higher serum C3 and C4 levels compared to non-survivors.
• Survivors exhibited significantly lower serum C3a and sC5b-9 levels than non-survivors.
• Multivariate logistic regression identified C3a and C4 levels as significant predictors of mortality.

Conclusions:

• Serum levels of complement factors are significantly associated with mortality in severe COVID-19 patients.
• Specific complement factors (C3a, C4) serve as important prognostic indicators for mortality.
• Further research into complement pathways may offer therapeutic targets for severe COVID-19.